Legislator Giurisprudenza & Legislazione
832.102 KVVOAMAL CH

Art. 71b Ordinanza del 27 giugno 1995 sull'assicurazione malattie (OAMal) - Assunzione dei costi di un medicamento omologato da Swissmedic non ammesso nell’elenco delle specialità

OAMal; Parte prima: Assicurazione obbligatoria delle cure medico-sanitarie; Titolo 4: Fornitori di prestazioni; Capitolo 3: Tariffe e prezzi
Apri la fonte ufficiale Atto completo (261 Articoli) Versione Markdown leggibile dalle macchine (.md)

Art. 71b OAMal · Assunzione dei costi di un medicamento omologato da Swissmedic non ammesso nell’elenco delle specialità

L’assicurazione obbligatoria delle cure medico-sanitarie assume i costi di un medicamento pronto per l’uso omologato da Swissmedic, non ammesso nell’elenco delle specialità, per un impiego che rientra o non rientra nell’informazione professionale se è adempiuta almeno una delle condizioni di cui all’articolo 71 a capoverso 1.

L’assicuratore stabilisce l’importo della rimunerazione d’intesa con il titolare dell’omologazione. Deve garantire che: a. nei casi di cui all’articolo 71 a capoverso 1 lettere a e c, sia applicato uno sconto di prezzo sul prezzo di fabbrica per la consegna determinato nel confronto con i prezzi praticati all’estero di cui all’articolo 65 b quater; il DFI stabilisce lo sconto di prezzo; tale sconto ammonta al massimo al 30 per cento; b. nei casi di cui all’articolo 71 a capoverso 1 lettera b, i costi assunti siano proporzionati al beneficio terapeutico; il DFI stabilisce uno sconto di prezzo sul prezzo di fabbrica per la consegna determinato nel confronto con i prezzi praticati all’estero di cui all’articolo 65 b quater in funzione delle categorie per la valutazione del beneficio terapeutico; tale sconto ammonta al massimo al 50 per cento.

In caso di costi terapeutici annuali o giornalieri molto bassi, l’assicuratore può prescindere da sconti di prezzo. Il DFI stabilisce quali costi terapeutici annuali o giornalieri sono da considerarsi molti bassi.

← Art. 71a OAMal Ordinanza del 27 giugno 1995 sull'assicurazione malattie (OAMal) - Obbligo d’assicurazione Art. 71c OAMal →

Ti chiedi come si applica questa disposizione alla tua fattispecie?

Analizza questa norma insieme alla giurisprudenza, ai commentari e alle disposizioni correlate in Legislator AI.

Apri in Legislator →

Decisioni giudiziarie che applicano questa disposizione (29)

200 2024 201 · be (Art. 71b KVV)
Claimant Denied Coverage for Unlisted Dronabinol Treatment Despite Severe Condition
The refusal of the appeal is based on the finding that the conditions for exceptional cost coverage according to Art. 71b KVV in conjunction with Art. 71a Abs. 1 KVV were not met.
608 2023 83 · fr (Art. 71b OAMal)
Swissmedic Drug Reimbursement Appeal Rejected Due to High Cost and Insufficient General Therapeutic Benefit
Cited in the reasoning regarding the insurer determining the coverage amount after consulting the authorization holder.
608 2023 83 · fr (Art. 71b al. 2 OAMal)
Swissmedic Drug Reimbursement Appeal Rejected Due to High Cost and Insufficient General Therapeutic Benefit
Cited in the reasoning regarding the insurer determining the coverage amount after consulting the authorization holder.
608 2023 83 · fr (art. 71b al. 1 OAMal)
Swissmedic Drug Reimbursement Appeal Rejected Due to High Cost and Insufficient General Therapeutic Benefit
This provision was the basis for examining the coverage of the drug, as it was authorized but not listed.
S 2020 91 · zg (Art. 71b Abs. 1 KVV)
Insured Person v. Mandatory Health Insurance (Cannabis Tincture Coverage)
The court analyzed whether cost coverage for the magistral preparation could be based on this article, which requires fulfilling the conditions of Art. 71a Abs. 1 KVV.
KV.2021.00038 · zh (Art. 71b Abs. 1 KVV)
Health Insurer Ordered to Cover ADHD Medication ELVANSE®
Regulates the conditions under which mandatory health insurance covers medications that are in the specialties list but used outside the approved indications or limitations.
AM.39.20.17.2021 · vd (art. 71b al. 1 OAMal cum art. 71a al. 1 let. a et b OAMal)
Insured Denied Coverage for Unlisted Medical Cannabis Oil
The court implicitly applied these articles to determine that the conditions for exceptional coverage of the cannabis oil were not met, leading to the rejection of the appeal.
VSBES.2020.70 · so (Art. 71b Abs. 1 KVV)
Insured v. Health Insurer Regarding Coverage for Unlisted Compounded Hormone Therapy
The court implicitly used this provision, in conjunction with Art. 71a Abs. 1 lit. b KVV, as the ground for rejecting the claim for cost coverage for the magistrally prepared hormone preparation.
KV.2018.00101 · zh (Art. 71b Abs. 1 KVV in Verbindung mit Art. 71a Abs. 1 lit. b KVV)
Insurer's Refusal to Cover Off-Label Cancer Drug Upheld Despite Initial Trial
The court determined that the requirements for an exceptional cost coverage for a non-listed drug under these provisions were not met, leading to the dismissal of the appeal.
KV.2018.00090 · zh (Art. 71b Abs. 1 KVV)
Patient v. Health Insurer: Denial of Spinraza Coverage for Adult SMA Patient Upheld
Used to determine the cost coverage of an approved drug not listed in the specialty list.
KV.2018.1 · sg (Art. 71b KVV)
Reimbursement of THC Tincture Costs Lacking FOPH Permit
The decision dictates referring the case back to the respondent for evidentiary completion and subsequent new decision regarding the claim for costs under this provision.
200 2019 102 · be (Art. 71b Abs. 1 KVV)
Insurer Refusal to Cover Delisted Leukemia Drug Upheld Due to Available Alternative
The court reviewed the possible cost coverage for the non-listed drug based on this provision, particularly in conjunction with Art. 71a Abs. 1 lit. b KVV.
200 2019 102 · be (Art. 71b KVV)
Insurer Refusal to Cover Delisted Leukemia Drug Upheld Due to Available Alternative
Cited in the reasoning as the relevant exceptional provision for non-listed drugs, whose conditions (via Art. 71a) were found not met.
200 2018 534 · be (Art. 71b Abs. 1 KVV i.V.m. Art. 71a Abs. 1 lit. b KVV)
Beneficiary v. Health Insurer (Tacrolimus Mouthwash Coverage)
The case was remanded to the respondent to assess costs based on the conditions set out in these provisions (E. 3.3).
A/2619/2017 · ge (Art. 71b OAMal)
Insured Denied Coverage for Unlisted Supplement Based on Principle of Legality
Although cited extensively in the reasoning, it was not explicitly cited in the dispositive orders.